A Phase 2 Trial of Standard Chemotherapy, With or Without BSI-201, in Patients With Triple Negative Metastatic Breast Cancer

This study has been completed.
Sponsor:
Collaborator:
BiPar Sciences
Information provided by (Responsible Party):
Sanofi
ClinicalTrials.gov Identifier:
NCT00540358
First received: October 4, 2007
Last updated: December 21, 2012
Last verified: December 2012
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: June 2010
  Primary Completion Date: November 2009 (Final data collection date for primary outcome measure)
  Certification or Request for Extension to Delay Results Received: July 21, 2011